Evidence map›Paper›PMID 29265725›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2018

Rationale and design for the Asia BP@Home study on home blood pressure control status in 12 Asian countries and regions.

Kazuomi Kario, Naoko Tomitani, Peera Buranakitjaroen, Chen-Huan Chen, Yook-Chin Chia, Romeo Divinagracia, Sungha Park, Jinho Shin, Saulat Siddique, Jorge Sison and 11 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Target blood pressure and control status in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2020
    Trial
  3. Trial
  4. Framework of Guidelines for Management of CKD in Asia.Kidney international reports · 2024
    Article
  5. Article
  6. Article
  7. Advancing hypertension management in Asia 2021, beyond COVID-19.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. The HOPE Asia Network activity for "zero" cardiovascular events in Asia: Overview 2020.Journal of clinical hypertension (Greenwich, Conn.) · 2020
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0002-8251-4480
Naoko TomitaniDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Peera BuranakitjaroenDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Chen-Huan ChenDepartment of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
Yook-Chin ChiaDepartment of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Romeo DivinagraciaUniversity of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.
Sungha ParkDivision of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.
Saulat SiddiquePunjab Medical Center, Lahore, Pakistan.
Jorge SisonDepartment of Medicine, Medical Center Manila, Ermita, Manila, Philippines.
Arieska Ann SoenartaDepartment of Cardiology and Vascular Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.
Guru Prasad SogunuruApollo Hospitals, Chennai, India.
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
Yuda TuranaDepartment of Neurology, Faculty of Medicine, Atma Jaya Catholic University of Indonesia, North Jakarta, Jakarta, Indonesia.
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524
Lawrence WongDepartment of Medicine and Therapeutics, Division of Neurology, Chinese University of Hong Kong, Hong Kong.
Yuqing ZhangDivisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Sirisawat WanthongDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0001-7541-5751
Hiroshi KanegaeDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
HOPE Asia Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Home blood pressure (BP) monitoring is endorsed in multiple guidelines as a valuable adjunct to office BP measurements for the diagnosis and management of hypertension. In many countries throughout Asia, physicians are yet to appreciate the significant contribution of BP variability to cardiovascular events. Furthermore, data from Japanese cohort studies have shown that there is a strong association between morning BP surge and cardiovascular events, suggesting that Asians in general may benefit from more effective control of morning BP. We designed the Asia BP@Home study to investigate the distribution of hypertension subtypes, including white-coat hypertension, masked morning hypertension, and well-controlled and uncontrolled hypertension. The study will also investigate the determinants of home BP control status evaluated by the same validated home BP monitoring device and the same standardized method of home BP measurement among 1600 or more medicated patients with hypertension from 12 countries/regions across Asia.

Indexed as

Blood Pressure Monitoring, AmbulatoryHypertensionAgedAntihypertensive AgentsAsiaFemaleHumansMalePatient Care ManagementPatient ComplianceProspective StudiesQuality ImprovementSphygmomanometersAntihypertensive AgentsAsiablood pressure controlhome blood pressure monitoringhypertension

Identifiers

PMID29265725
PMCPMC8030943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.